PROTECT-V Clinical Trial

PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V) [email protected]

[Lisa wood @lisawood78]

Protect-V trial is open to recruitment here @WestSuffolkNHS! Get in touch with the Clinical Research Team for more info! 👍🏻 🦠 @PROTECT_CCTU

[PROTECT-V Clinical Trial @PROTECT_CCTU]

Thank you so much! 👏🙏

[DCHFT Research @DCHFT_Research]

Starting the day with a HUGE thank you to our @PROTECT_CCTU trial participants. The last final appointment has taken place @DCHFT - now for ensuring the data is in tip top order for the trial office to work on! #Covid #TeamDCH #ResearchActiveTrust #KidneyDisease #NHS #Thankyou

[PROTECT-V Clinical Trial @PROTECT_CCTU]

Congratulations to all our sites who have recruited into the niclosamide arm of @PROTECT_CCTU. We have now enrolled over 1500 patients across🇬🇧 and 🇮🇳! Thanks to everyone for their ongoing support. @CUH_NHS @Kidney_Research @lifearc1 @RonaMarieSmith @CambridgeBRC

[Sarah Cottee @CotteeSarah]

@SKirkhamcardio @evusheld4theuk https://t.co/qNpoRZlsvD If you don’t have any immunity you’d qualify for this study

[Alice Jasper @_alicejasper]

Excited to be working on the @PROTECT_CCTU clinical trial! Well done to everyone on the team who has started recruitment and thanks to all the volunteers who it wouldn't be possible without. #BePartOfResearch

[rona smith @RonaMarieSmith]

@NIHR_Cam_CRF @itvanglia @PROTECT_CCTU @CambridgeBRC @CUH_NHS Many thanks for highlighting the addition of sotrovimab to the PROTECT-V platform. Just a point of accuracy, Julia is receiving sotrovimab, not niclosamide, which was the first agent tested in this study

[University Hospitals Birmingham @uhbtrust]

Andrew McKniff from Redditch has been one of the first participants to take part in the #Sotrovimab arm of the @PROTECT_CCTU and received his dose yesterday at the Queen Elizabeth Hospital Birmingham.

Read more here: https://t.co/8UQ9vE4ucB

@GSK @Dr_D_Dosanjh @RonaMarieSmith

[Cambridge University Hospitals NHS @CUH_NHS]

📺 Tune into @itvanglia at 6.00pm today and @BBCLookEast at 6.30pm to see Dr Rona Smith and patient Julia Hulme being interviewed about the PROTECT-V trial and the ongoing fight against #Covid19.

@PROTECT_CCTU

[Birmingham Health Partners @BHPComms]

.@uhbtrust has begun roll-out of a drug trial which could prevent vulnerable & immunocompromised patients from catching #Covid19, particularly those who don't respond well to vaccinations. The #Sotrovimab arm of the @PROTECT_CCTU is co-led by @Dr_D_Dosanjh
https://t.co/jRkWkcMp0b

[University Hospitals Birmingham @uhbtrust]

We are delighted to support the #Sotrovimab arm of @PROTECT_CCTU that launched yesterday for patient groups who are not able to mount a protective immune response to COVID-19 vaccination.

Read more here 👉 https://t.co/C1BaQfrsD4
@Dr_D_Dosanjh @UHBResearch @RonaMarieSmith

[UHBRespResearch @RespResearchUHB]

@ShannonB @AlexRichter3 @PROTECT_CCTU @ImmunologyUoB @Dr_D_Dosanjh You may be eligible if you are an adult who is immunocompeomised for whatever reason - main groups: those on dialysis, those with primary immunodeficiency, Hameonc or oncology patients on chemo or on immunosuppression for any reason eg organ transplant or autoimmune disease.

[UHBRespResearch @RespResearchUHB]

@ShannonB @AlexRichter3 @PROTECT_CCTU @ImmunologyUoB @Dr_D_Dosanjh Hi Shannon - recruitment has just begun and we're looking for 1760 participants from across the country - if you're not a @uhbtrust patient - next centre to open will be @CUH_NHS - planning for 20 centre to open around the UK

[AMcM @aislingcmcmahon]

@PROTECT_CCTU @Dr_D_Dosanjh @uhbtrust @CUH_NHS @Kidney_Research @RonaMarieSmith Fantastic example of the value added by medical research charities - @LifeArc and @Kidney_Research collaborating to establish the PROTECT-V trials platform. Thank you @LifeArc for funding this with us. @AMRC @CharlieTomson @cranford59 @kidneydoc101 @RonaMarieSmith

[Professor Alex Richter @AlexRichter3]

Great news to get the first patient recruited to the Sotrovimab prophylactic monoclonal arm of Protect-V and screening bloods smoothly through our lab 💪@ImmunologyUoB @RespResearchUHB @Dr_D_Dosanjh

[PROTECT-V Clinical Trial @PROTECT_CCTU]

Congratulations to @Dr_D_Dosanjh and the team @uhbtrust! Great news that the #sotrovimab arm of @PROTECT_CCTU is up and running for patients who have not mounted an immune response to COVID vaccination. @CUH_NHS @Kidney_Research @RonaMarieSmith

[DCHFT Research @DCHFT_Research]

Another participant @DCHFT has joined the @PROTECT_CCTU trial this week - thank you so much! #RenalResearch #covid19 #niclosamide #NHS #BePartofResearch

[DCHFT Research @DCHFT_Research]

Another participant has joined the @PROTECT_CCTU trial this morning - thats three in the last week! Thanks so much to our renal patients @DCHFT for being so kind with your time, particularly in this heat! #TeamDCH #COVID19 #niclosamide #bepartofresearch #ResearchActiveTrust

[PROTECT-V Clinical Trial @PROTECT_CCTU]

@DCHFT_Research @dchft_pharmacy @DCHFT Great news. Thanks so much for your ongoing support!

[DCHFT Research @DCHFT_Research]

The Renal team have welcomed 4 new participants to the @PROTECT_CCTU study. Thank you for being so keen to take part and to @dchft_pharmacy for processing our prescriptions speedily. Looking forward to welcoming more in the coming weeks! #TeamDCH #TrialBlazers @DCHFT #Covid